AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells

Biochemical and Biophysical Research Communications

Volumn 324, Issue 4, 2004, Pages 1204-1209

  Cacicedo, Jose M ^a   Yagihashi, Norito ^b   Keaney Jr , John F ^a   Ruderman, Neil B ^a   Ido, Yasuo ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

AMP activated protein kinase; Atherosclerosis; Free fatty acids; Human umbilical vein endothelial cells; Inflammation; Nuclear factor B; Tumor necrosis factor

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CYCLIC AMP; CYTOKINE; ENZYME ACTIVATOR; FATTY ACID; GLUCOCORTICOID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PALMITIC ACID; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; MULTIENZYME COMPLEX; PALMITIC ACID DERIVATIVE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPOSURE; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TIME; UMBILICAL VEIN; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSACTIVATION; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MULTIENZYME COMPLEXES; NF-KAPPA B; PALMITATES; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 14344257169     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.177     Document Type: Article

References (39)

1. D.G. Hardie, D. Carling, and M. Carlson The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67 1998 821 855
2. B.E. Kemp, D. Stapleton, D.J. Campbell, Z.P. Chen, S. Murthy, M. Walter, A. Gupta, J.J. Adams, F. Katsis, B. van Denderen, I.G. Jennings, T. Iseli, B.J. Michell, and L.A. Witters AMP-activated protein kinase, super metabolic regulator Biochem. Soc. Trans. 31 2003 162 168
3. N.B. Ruderman, J.M. Cacicedo, S. Itani, N. Yagihashi, A.K. Saha, J.M. Ye, K. Chen, M. Zou, D. Carling, G. Boden, R.A. Cohen, J. Keaney, E.W. Kraegen, and Y. Ido Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes Biochem. Soc. Trans. 31 2003 202 206
4. D.G. Hardie, J.W. Scott, D.A. Pan, and E.R. Hudson Management of cellular energy by the AMP-activated protein kinase system FEBS Lett. 546 2003 113 120
5. R. Bergeron, J.M. Ren, K.S. Cadman, I.K. Moore, P. Perret, M. Pypaert, L.H. Young, C.F. Semenkovich, and G.I. Shulman Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis Am. J. Physiol. Endocrinol. Metab. 281 2001 E1340 E1346
6. E.O. Ojuka Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle Proc. Nutr. Soc. 63 2004 275 278
7. H. Zong, J.M. Ren, L.H. Young, M. Pypaert, J. Mu, M.J. Birnbaum, and G.I. Shulman AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation Proc. Natl. Acad. Sci. USA 99 2002 15983 15987
8. M. Suwa, H. Nakano, and S. Kumagai Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles J. Appl. Physiol. 95 2003 960 968
9. Y. Ido, D. Carling, and N. Ruderman Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation Diabetes 51 2002 159 167
10. M.E. Widlansky, N. Gokce, J.F. Keaney Jr., and J.A. Vita The clinical implications of endothelial dysfunction J. Am. Coll. Cardiol. 42 2003 1149 1160
11. J.A. Beckman, A.B. Goldfine, M.B. Gordon, L.A. Garrett, and M.A. Creager Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans Circ. Res. 90 2002 107 111
12. T.F. Luscher, M.A. Creager, J.A. Beckman, and F. Cosentino Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II Circulation 108 2003 1655 1661
13. M.A. Creager, T.F. Luscher, F. Cosentino, and J.A. Beckman Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I Circulation 108 2003 1527 1532
14. T. Collins, and M.I. Cybulsky NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest. 107 2001 255 264
15. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
16. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
17. C. Panzer, A. Brieke, and N.B. Ruderman Prevention of type 2 diabetes and its macrovascular complications: whom, when, and how should we treat? Curr. Opi. Endocrinol. Diab. 10 2003 229 236
18. M. Toborek, Y.W. Lee, R. Garrido, S. Kaiser, and B. Hennig Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells Am. J. Clin. Nutr. 75 2002 119 125
19. S.I. Itani, N.B. Ruderman, F. Schmieder, and G. Boden Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha Diabetes 51 2002 2005 2011
20. A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P.M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, M. Morcos, M. Hofmann, H. Tritschler, B. Weigle, M. Kasper, M. Smith, G. Perry, A.M. Schmidt, D.M. Stern, H.U. Haring, E. Schleicher, and P.P. Nawroth Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB Diabetes 50 2001 2792 2808
21. R.F. Chen Removal of fatty acids from serum albumin by charcoal treatment J. Biol. Chem. 242 1967 173 181
22. P. Dandona, R. Weinstock, K. Thusu, E. Abdel-Rahman, A. Aljada, and T. Wadden Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J. Clin. Endocrinol. Metab. 83 1998 2907 2910
23. C. Weigert, K. Brodbeck, H. Staiger, C. Kausch, F. Machicao, H.U. Haring, and E.D. Schleicher Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB J. Biol. Chem. 279 2004 23942 23952
24. H.J. Park, Y.W. Lee, B. Hennig, and M. Toborek Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway Nutr. Cancer 41 2001 126 134
25. N.R. Ruderman, and M. Prentki AMP kinase and malonyl CoA: targets for therapy of the metabolic syndrome Nat. Rev. Drug Discov. 3 2004 1 13
26. Y. Ido, N. Yagihashi, J.M. Cacicedo, and N.R. Ruderman AMP-kinase activation prevents TNF-alpha induced ICAM expression by inhibiting NF-kB transactivation but not by inhibiting their translocation or DNA-binding Diabetes 51 2002 A458
27. P. Libby, and D.X. Zhao Allograft arteriosclerosis and immune-driven angiogenesis Circulation 107 2003 1237 1239
28. N. Ruderman, and G. Shulman The Metabolic syndrome L. DeGroot J. Jameson Endocrinology 2004 Elsevier Philadelphia Chapter 61
29. P. Han, U. Toyoyoshi, A.C. Haber, T.K. Lam, L. Stavar, C. Tang, G.I. Fantus, and A. Giacca Free fatty acid-induced hepatic insulin resistance: evidence for a protein kinase C (PKC)-delta, oxidative stress and IKKbeta (Inhibitor of NF-kappaB) signaling pathway Diabetes 53 2004 A48
30. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
31. N.B. Ruderman, J.R. Williamson, and M. Brownlee Glucose and diabetic vascular disease FASEB J. 6 1992 2905 2914
32. G.M. Pieper, and H. Riaz ul Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C J. Cardiovasc. Pharmacol. 30 1997 528 532
33. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
34. X. Du, K. Stocklauser-Farber, and P. Rosen Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic. Biol. Med. 27 1999 752 763
35. A. Bierhaus, S. Chevion, M. Chevion, M. Hofmann, P. Quehenberger, T. Illmer, T. Luther, E. Berentshtein, H. Tritschler, M. Muller, P. Wahl, R. Ziegler, and P.P. Nawroth Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells Diabetes 46 1997 1481 1490
36. H.J. Smartt, D.J. Elder, D.J. Hicks, N.A. Williams, and C. Paraskeva Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells Br. J. Cancer 89 2003 1358 1365
37. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, J. Zhang, R. Cao, S.D. Yan, J. Brett, and D. Stern Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J. Clin. Invest. 96 1995 1395 1403
38. A.M. Schmidt, O. Hori, R. Cao, S.D. Yan, J. Brett, J.L. Wautier, S. Ogawa, K. Kuwabara, M. Matsumoto, and D. Stern RAGE: a novel cellular receptor for advanced glycation end products Diabetes 45 Suppl. 3 1996 S77 80
39. Z. Dagher, N. Ruderman, K. Tornheim, and Y. Ido Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells Circ. Res. 88 2001 1276 1282